EUVIMEDEUVIMED entdecken
Crossref

The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease

Devika Kapuria, Rajiv Chhabra

Journal of Exploratory Research in Pharmacology · 2017

DOI: 10.14218/jerp.2016.00016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Exploratory Research in Pharmacology, 2017. Verfasst von Devika Kapuria und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kapuria, D., & Chhabra, R. (2017). The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease. Journal of Exploratory Research in Pharmacology. https://doi.org/10.14218/jerp.2016.00016

Vancouver

Kapuria D, Chhabra R. The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease. Journal of Exploratory Research in Pharmacology. 2017. doi:10.14218/jerp.2016.00016

BibTeX
@article{Kapuria2017,
  author = {Kapuria, Devika and Chhabra, Rajiv},
  title = {The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease},
  journal = {Journal of Exploratory Research in Pharmacology},
  year = {2017},
  doi = {10.14218/jerp.2016.00016}
}
Kostenlos starten →